PMS-pathway control state: Difference between revisions
No edit summary |
mNo edit summary |
||
Line 17: | Line 17: | ||
::::ยป [[Additive effect of convergent electron flow]] | ::::ยป [[Additive effect of convergent electron flow]] | ||
::::ยป [[Respiratory_complexes#Respiratory_complexes_-_more_than_five |Respiratory complexes - more than five]] | ::::ยป [[Respiratory_complexes#Respiratory_complexes_-_more_than_five |Respiratory complexes - more than five]] | ||
::::ยป [[Convergent electron flow]] | ::::ยป [[Convergent electron flow]] | ||
::::ยป [[NS-pathway control state]] | ::::ยป [[NS-pathway control state]] |
Revision as of 17:18, 22 January 2019
Description
PMS: Pyruvate & Malate & Succinate.
MitoPathway control: CI&II
Pyruvate (P) is oxidatively decarboxylated to acetyl-CoA and CO2, yielding NADH catalyzed by pyruvate dehydrogenase. Malate (M) is oxidized to oxaloacetate by mt-malate dehydrogenase located in the mitochondrial matrix. Condensation of oxaloacate with acetyl-CoA yields citrate (citrate synthase). This documents an additive effect of convergent CI&II electron flow to the Q-junction, with consistent results obtained with permeabilized muscle fibres and isolated mitochondria (Gnaiger 2009).
Abbreviation: PMS
Reference: Gnaiger 2014 MitoPathways - Chapter 5.5
MitoPedia concepts:
SUIT state
PMSL
PMS pathway in the LEAK state can be evaluated in the following SUIT protocols:
PMSP
PMS pathway in the OXPHOS state can be evaluated in the following SUIT protocols:
PMSE
PMS pathway in the ET state can be evaluated in the following SUIT protocols:
-
- DL-Protocol for permeabilized fibers (pfi): SUIT-004 O2 pfi D010
-